229 related articles for article (PubMed ID: 16299807)
1. Molecular mechanisms of hepatic metastasis in colorectal cancer.
Rudmik LR; Magliocco AM
J Surg Oncol; 2005 Dec; 92(4):347-59. PubMed ID: 16299807
[TBL] [Abstract][Full Text] [Related]
2. [Molecular mechanism of liver metastasis from colorectal cancer].
Fang YJ; Wan DS
Ai Zheng; 2008 May; 27(5):549-54. PubMed ID: 18479609
[TBL] [Abstract][Full Text] [Related]
3. Targeting death receptors in bladder, prostate and renal cancer.
O'Kane HF; Watson CJ; Johnston SR; Petak I; Watson RW; Williamson KE
J Urol; 2006 Feb; 175(2):432-8. PubMed ID: 16406966
[TBL] [Abstract][Full Text] [Related]
4. Tumour-associated angiogenesis in human colorectal cancer.
Rmali KA; Puntis MC; Jiang WG
Colorectal Dis; 2007 Jan; 9(1):3-14. PubMed ID: 17181841
[TBL] [Abstract][Full Text] [Related]
5. Biology of colorectal liver metastases: A review.
Bird NC; Mangnall D; Majeed AW
J Surg Oncol; 2006 Jul; 94(1):68-80. PubMed ID: 16788948
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and functional differences between human liver cancer endothelial cells and liver sinusoidal endothelial cells.
Wu LQ; Zhang WJ; Niu JX; Ye LY; Yang ZH; Grau GE; Lou JN
J Vasc Res; 2008; 45(1):78-86. PubMed ID: 17901709
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389
[TBL] [Abstract][Full Text] [Related]
8. New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression.
Leeman MF; Curran S; Murray GI
J Pathol; 2003 Dec; 201(4):528-34. PubMed ID: 14648655
[TBL] [Abstract][Full Text] [Related]
9. [Extracellular matrix degradation enzymes: important factors in liver metastasis of colorectal cancer and good targets for anticancer metastatic therapy].
Ichikawa Y; Ishikawa T; Tanaka K; Togo S; Shimada H
Nihon Geka Gakkai Zasshi; 2001 May; 102(5):376-80. PubMed ID: 11393999
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in colorectal cancer metastasis.
de Krijger I; Mekenkamp LJ; Punt CJ; Nagtegaal ID
J Pathol; 2011 Aug; 224(4):438-47. PubMed ID: 21706478
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
[TBL] [Abstract][Full Text] [Related]
12. Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
Fukunaga S; Maeda K; Noda E; Inoue T; Wada K; Hirakawa K
Oncology; 2006; 71(3-4):204-11. PubMed ID: 17641542
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanisms in development of colorectal cancer metastasis].
Bognár G; Ledniczky G; István G; Ondrejka P
Magy Seb; 2006 Oct; 59(5):342-9. PubMed ID: 17201342
[TBL] [Abstract][Full Text] [Related]
14. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH
Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
[TBL] [Abstract][Full Text] [Related]
15. Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables.
Cross SS; Harrison RF; Balasubramanian SP; Lippitt JM; Evans CA; Reed MW; Holen I
J Clin Pathol; 2006 Jul; 59(7):716-20. PubMed ID: 16489180
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis and hypoxic factors in colorectal cancer.
Rasheed S; McDonald PJ; Northover JM; Guenther T
Pathol Res Pract; 2008; 204(7):501-10. PubMed ID: 18541387
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors.
Leupold JH; Yang HS; Colburn NH; Asangani I; Post S; Allgayer H
Oncogene; 2007 Jul; 26(31):4550-62. PubMed ID: 17297470
[TBL] [Abstract][Full Text] [Related]
19. [Invasiveness and metastasis in colorectal cancer: P53 gene alteration associated with hepatic metastasis].
Fushida S; Miwa K
Nihon Rinsho; 2003 Sep; 61 Suppl 7():107-10. PubMed ID: 14574865
[No Abstract] [Full Text] [Related]
20. Molecular determinants in the biology of liver metastasis.
Radinsky R; Ellis LM
Surg Oncol Clin N Am; 1996 Apr; 5(2):215-29. PubMed ID: 9019348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
